Nexalin Technology, Inc. Share Price
NASDAQ: NXL | Micro Cap$1.68
+$1.68 (--%) Last updated on 29 Oct, 2026 | 01:06 ISTNexalin Technology, Inc. Stock Performance
Nexalin Technology, Inc. Share Price Chart
$1.68$1.68
L
H
Nexalin Technology, Inc. Quarterly Profit & Loss
All figures in USD
Nexalin Technology, Inc. Annual Profit & Loss
All figures in USD
About Nexalin Technology, Inc.
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Nexalin Technology, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $8.58 | $1.68 | -68.10% |
Sep 2026 | $5.47 | $5.25 | +1,615.69% |
Aug 2026 | $0.33 | $0.31 | -15.00% |
Jul 2026 | $0.35 | $0.36 | +7.14% |
Jun 2026 | $0.61 | $0.34 | -44.28% |
May 2026 | $0.38 | $0.60 | +74.78% |
Apr 2026 | $0.36 | $0.34 | -1.99% |
Mar 2026 | $0.47 | $0.35 | -25.11% |
Feb 2026 | $0.56 | $0.47 | -16.07% |
Jan 2026 | $0.64 | $0.56 | +0.00% |
Dec 2025 | $0.97 | $0.56 | -48.15% |
Nov 2025 | $1.49 | $1.08 | -29.41% |